Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

A Study of NE3107 (Bezisterim) in Early Parkinson’s Disease (SUNRISE-PD): Baseline Demographics and Characteristics

Author:Palumbo, Joseph   Ahlem, Clarence   Reading, Chris   Zhang, Jeffrey   Stacy, Mark   

Session Name:P6: Movement Disorders: Parkinson's Disease Emerging Therapeutics 1  

Topic:Movement Disorders  

Program Number:P6.017  

Author Institution:BioVie Inc., Carson City, NV  Princeton Pharmatech LLC., Princeton, NJ  MUSC Department of Neurology, Charleston, SC  

Subgroup Analyses of the Phase Three Tolebrutinib in Non-relapsing Secondary Progressive Multiple Sclerosis (nrSPMS) HERCULES Trial

Author:Fox, Robert J.   Bar-Or, Amit   Traboulsee, Anthony   Oreja-Guevara, Celia   Giovannoni, Gavin   Vermersch, Patrick   Syed, Sana   Li, Ye   Vargas, Wendy S.   Turner, Timothy J.   Wallstroem, Erik   Reich, Daniel S.   

Session Name:P7: Multiple Sclerosis: Clinical Trials 1  

Topic:Multiple Sclerosis  

Program Number:P7.004  

Author Institution:Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, United States, OH  Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, University of Pennsylvania, Philadelphia, United States, PA  The University of British Columbia, Division of Neurology, Vancouver, Canada, BC, Canada  Departamento de Neurologia, Hospital Clinico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain  Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain, Spain  Queen Mary University London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom, United Kingdom  University of Lille, Inserm U1172, CHU Lille, FHU Precise, Lille, France, France  Sanofi, Cambridge, United States, MA  Sanofi, Bridgewater, United States, MA  Translational Neuroradiology Section, National Institutes of Health, Bethesda, United States, MD  

Efficacy and Safety of IL-6 Inhibitors in Neuromyelitis Optica Spectrum Disorder (NMOSD): A Network Meta-analysis

Author:Raj, Rishu   Sharma, Arkansh   Datta, Abhigyan   Kaur, Gurleen   Duggal, Ashish   Nithyanandam, Allimuthu   Suresh, Vinay   

Session Name:P7: Autoimmune Neurology: NMOSD/MOGAD 6  

Topic:Autoimmune Neurology  

Program Number:P7.005  

Author Institution:Atal Bihari Vajpayee Institute of Medical Sciences and Dr. RML Hospital, New Delhi, India, Ghaziabad, India  Government Medical College, Omandurar, Chennai, Tamil Nadu, India, Chennai, India  University of Minnesota, USA, Minneapolis, MN  All India Institute Of Medical Sciences, Patna, India , Abohar, India  Atal Bihari Vajpayee Institute of Medical Sciences, New Delhi, New Delhi, India  Department of Neurology, Tamil Nadu Government Multi-Super Speciality Hospital, Omandurar Government Estate, Chennai, India, Chennai, India  University of Oxford, United Kingdom, United Kingdom  

Clinical and Imaging Features of Osmotic Demyelination Syndrome due to Glucose Disturbances: A Systematic Review of Case Reports and Case Series

Author:Alasmar, Deya'a   Alzoubi, Ahmad   Othman, Ma’moun   Alzu’bi, Dema   Jbarah, Ahda   Kaddouh, MD, MHS, Firas   

Session Name:P7: Neurocritical Care: Toxins and Med Effects 2  

Topic:Neurocritical Care  

Program Number:P7.008  

Author Institution:Hashemite University, Jordan, Amman, Jordan  Hashemite University, Jordan, Jordan  Emory University, GA, Atlanta, GA  Department of Neurology, University of Arizona College of Medicine – Tucson, AZ  

Double Trouble: How a Persistent Trigeminal Artery Causes Stroke by Two Pathways

Author:Xiao, Kangni   Vallejos, Andrew   Trifan, Gabriela   

Session Name:P7: Cerebrovascular Disease and Interventional Neurology: Rare Clinical Cases  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P7.011  

Author Institution:University of Illinois, Chicago, IL  University of Illinois, Peoria, Peoria, IL  UIC, Department of Neurology, Chicago, IL